Boston Scientific Scimed Patents – Insights & Stats (Updated 2023)
October 27, 2023
Boston Scientific Scimed has a total of 19779 patents globally, out of which 9921 have been granted. Of these 19779 patents, more than 49% patents are active. The United States of America is where Boston Scientific Scimed has filed the maximum number of patents, followed by Europe and China. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Boston Scientific Scimed.
Boston Scientific Scimed was founded in 1972. The company’s line of business includes the manufacturing of medical, surgical, ophthalmic and veterinary instruments and apparatus.
Do read about some of the most popular patents of Boston Scientific Scimed which have been covered by us in this article and also you can find Boston Scientific Scimed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Boston Scientific Scimed patent portfolio.
How many patents does the Founder and CEO of Boston Scientific Scimed have?
The Founder John Abele has 3 patents has 180 and Pete M. Nicholas have 6 patents and the CEO Michael F. Mahoney have 38 patents.
How many patents does Boston Scientific Scimed have?
Boston Scientific Scimed has a total of 19779 patents globally. These patents belong to 6203 unique patent families. Out of 19779 patents, 9871 patents are active.
How Many Patents did Boston Scientific Scimed File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
Boston Scientific Scimed Applications Filed
Boston Scientific Scimed Patents Granted
2023
174
458
2022
647
708
2021
1017
730
2020
1460
836
2019
1124
775
2018
1099
689
2017
1067
742
2016
1213
720
2015
1116
550
2014
1306
621
2013
1028
586
2012
1051
536
How many Boston Scientific Scimed patents are Alive/Dead?
Worldwide Patents
How Many Patents did Boston Scientific Scimed File in Different Countries?
Countries in which Boston Scientific Scimed Filed Patents
Country
Patents
United States Of America
8594
Europe
2302
China
1230
Japan
1227
Germany
1111
Austria
941
Australia
607
Canada
530
Korea (South)
211
Spain
105
India
20
United Kingdom
20
Italy
19
New Zealand
13
Brazil
5
Israel
5
Denmark
4
Netherlands
3
Russia
3
Hong Kong (S.A.R.)
3
Poland
2
Portugal
2
Mexico
1
Where are Research Centers of Boston Scientific Scimed Patents Located?
10 Best Boston Scientific Scimed Patents
US20060252993A1 is the most popular patent in the Boston Scientific Scimed portfolio. It has received 1491 citations so far from companies like Avinger, Inc., Olympus Corporation and Ethicon Endo-Surgery, Inc.
Below is the list of 10 most cited patents of Boston Scientific Scimed:
How many inventions of other companies were rejected due to Boston Scientific Scimed patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Boston Scientific Scimed invention. They couldn’t because Boston Scientific Scimed had protected those before them.
Examiners at the USPTO referred 3354 Boston Scientific Scimed patents in 22765 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Boston Scientific Scimed patent portfolio are Covidien, Cook Medical Technologies and Biosense Webster.
List of the Companies whose Patents were rejected citing Boston Scientific Scimed –
Company
Number of Patent Applications that faced Rejection Citing Boston Scientific Scimed Patents
Number of Rejections (102 & 103)
Covidien
340
875
Cook Medical Technologies
294
762
Biosense Webster
220
577
Abbott Cardiovascular Systems
187
490
Medtronic
155
415
St Jude Medical Cardiology Division
141
392
Olympus Corporation
141
231
Terumo Kabushiki Kaisha
113
272
C R Bard
99
272
Philips
80
192
Count of 102 and 103 Type Rejections based on Boston Scientific Scimed Patents
TopBoston Scientific Scimed Patents used in Rejecting Most Patent Applications
Patent Number
Count of Rejected Applications
US7922650B2
84
US7291146B2
50
US8496653B2
32
US7846107B2
26
US7381219B2
26
US8628465B2
25
US8103327B2
25
US8128617B2
25
US20080188928A1
25
US8353860B2
23
US7717843B2
23
US20060252993A1
23
US8485966B2
22
US7955255B2
22
US8535368B2
21
What Percentage of Boston Scientific Scimed US Patent Applications were Granted?
Boston Scientific Scimed (Excluding its subsidiaries) has filed 10430 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7493 have been granted leading to a grant rate of 80.28%.
Below are the key stats of Boston Scientific Scimed patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Boston Scientific Scimed?
Law Firm
Total Applications
Success Rate
Seager Tufte & Wickhem
2339
81.09%
Bookoff Mcandrews
1136
80.04%
Vidas Arrett & Steinkraus
963
81.18%
Brake Hughes Bellermann
709
95.44%
Fish & Richardson
319
49.12%
Faegre Drinker Biddle & Reath
309
79.52%
Hunton Andrews Kurth
226
61.78%
Fay Kaplun & Marcin
219
70.16%
Vista Ip Law Group
164
35.85%
Boston Scientific Corporation
136
83.09%
What are Boston Scientific Scimed key innovation segments?
What Technologies are Covered by Boston Scientific Scimed?
The chart below distributes patents filed by Boston Scientific Scimed in different countries on the basis of the technology protected in patents. It also represents the markets where Boston Scientific Scimed thinks it’s important to protect particular technology inventions.
R&D Focus: How has Boston Scientific Scimed search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Boston Scientific Scimed?
Barracuda Networks has a total of 231 patents globally, out of which 122 have been granted. Of these 231 patents, more than 51% patents are active. United States of America is where Barracuda Networks has filed the maximum number of patents, followed by Korea (South) and Europe (EPO). Parallelly, United
Locus Biosciences has a total of 48 patents globally, out of which 1 have been granted. Of these 48 patents, 50% patents are active. The United States of America is where Locus Biosciences has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, United States of
Axicle has a total 29 patents globally, out of which 30028 have been granted. Of these 9 patents, more than 77% patents are active. United States of America is where Axicle has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America seems
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.